1. Lu, L.*, Zhu, Y., Jiang, S. (2016). Is α4β7 a hiding target for HIV vaccines? Science. http://science.sciencemag.org/content/354/6309/197.e-letters. IF=34.661.

2. Zhu, Y., Su, S.,Wang, Q., Qin, L.,Shi, L., Jiang, S.*, Lu. L.*, Ye, S.*, Zhang, R.* (2016). Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations. Sci. Rep. 6:31983. IF=5.228.

3. Li, W., Yu, F., Wang, Q., Qi, Q.Q., Su, S., Xie, L., Lu, L.*, Jiang, S.* (2016). Co-delivery of HIV-1 entry inhibitor and non-nucleoside reverse transcriptase inhibitor shuttled by nanoparticles: a novel cocktail therapeutic strategy for antiviral therapy. AIDS. 30(6): 827-837. IF=4.407.

4. He, B., Jiang, S., Lu, L*. (2016). Normal human sera contain heat-sensitive factor(s) to enhance H7N9 influenza virus infection. J. Infect. 72(1):123-125. IF=4.38

5. He, B., Fu, Y., Xia, S., Yu, F., Wang, Q., Lu, L.*, Jiang, S.* (2016). Intranasal application of polyethyleneimine suppressed influenza virus infection in mice. Emerg. Microbes Infect. 5: e41. IF=4.012.

6. Sun, Z., Zhu, Y., Wang, Q., Ye, L., Dai, Y., Su, S., Yu, F., Ying, T., Yang, C., Jiang, S.*, Lu, L.* (2016). An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induced antibodies to neutralize HIV-1 and to activate ADCC reporter gene. Emerg. Microbes Infect. 5: e65. IF=4.012.

7. He, B., Xia, S., Yu, F., Fu, Y., Li, W., Wang, Q., Lu, L.*, Jiang, S.* (2016). The putative suppressing effect of IgG Fc-conjugated hemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines. J. Gen. Virol. 97(2):327-33. IF=3.192.

8. Lu, L., Yu, F., Cai, L., Debnath, A., Jiang, S.* (2016). Development of small molecule HIV entry inhibitors specifically targeting gp120 or gp41. Curr. Top. Med. Chem. 16(10):1074-90. IF=2.9.